Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Vascular Research|May 9, 2008
Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cellsSaima Muzaffar, Nilima Shukla, Mark Bond, et al.
Journal of Biomolecular Structure & Dynamics|June 14, 2022
Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with in vitro and in silico studiesMuhammad Yasin, Wardah Shahid, Muhammad Ashraf, et al.
Bioorganic Chemistry|August 17, 2021
Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studiesBushra Bashir, Wardah Shahid, Muhammad Ashraf, et al.
Bioorganic Chemistry|August 20, 2021
Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studiesWardah Shahid, Muhammad Ashraf, Muhammad Saleem, et al.
ACS Omega|June 20, 2022
4-Chlorophenyl-N-furfuryl-1,2,4-triazole Methylacetamides as Significant 15-Lipoxygenase Inhibitors: an Efficient Approach for Finding Lead Anti-inflammatory CompoundsMuhammad Yasin, Wardah Shahid, Muhammad Ashraf, et al.
Bioorganic Chemistry|December 15, 2020
Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studiesSaima Muzaffar, Wardah Shahid, Naheed Riaz, et al.
Bioorganic Chemistry|September 18, 2022
Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studiesBushra Bashir, Naheed Riaz, Syeda Abida Ejaz, et al.
Bioorganic Chemistry|December 6, 2023
Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studiesZahid Nawaz, Naheed Riaz, Muhammad Saleem, et al.
Heliyon|September 16, 2024
Probing N-substituted 4-(5-mercapto-4-ethyl-4H-1,2,4-triazol-3-yl)-N-phenylpiperdine-1-carboxamides as potent 15-LOX inhibitors supported with ADME, DFT calculations and molecular docking studiesZahid Nawaz, Naheed Riaz, Muhammad Saleem, et al.
Arthritis Research & Therapy|February 17, 2022
The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week studySang-Cheol Bae, Damon L Bass, Myron Chu, et al.
Pageof 2